Press releases

High ranking representatives of politics and science inaugurated the new building for the DZNE on the grounds of the University Clinic Tübingen on January 27.

A laboratory study indicates that the main protein involved in Parkinson’s disease pathology does not behave as a ‘prion’ when overexpressed. Researchers led by Prof. Donato Di Monte report on this in the journal “BRAIN”.

So-called “Imaging techniques” are essential for understanding memory formation and cognition and the development of new therapies against brain diseases. The DZNE is now focusing its nationwide expertise in the field under the umbrella of the “National Neuroimaging…

A DZNE study supports the hypothesis that memories are encoded with the help of chemical labels on the DNA. The findings are reported in „Nature Neuroscience“.

The molecular biologist Frank Bradke, group leader at the DZNE and professor for neurobiology at the University of Bonn, will be awarded the “Gottfried Wilhelm Leibniz Prize”, which is endowed with 2.5 million euros.

This morning, Saxony-Anhalt’s Minister of Science Hartmut Möllring inaugurated the new MR-PET device at the German Center for Neurodegenerative Diseases, site Magdeburg. The MR-PET device has opened up a whole new range of possibilities for dementia research and will have a…

Specific forms of epilepsy may manifest as early as in the first weeks of life. A new laboratory study shows that a preventive therapeutic strategy can be successful if it is applied within a time window critical to brain development.

The neurologist Michela Deleidi was successful in her application for a “Helmholtz Young Investigators Group”, after going through a competitive selection procedure. She will receive approximately 1.25 million Euros over the next five years to develop her projects at the…

Universities, research institutions, scientific organizations and regional authorities in the Science Region of Bonn have now all joined the current debate on xenophobia in Germany with a common appeal. The presidents, deans, directors, mayor and district administrator are…

In cooperation with colleagues in Munich and Göttingen, researchers at the DZNE in Bonn have analyzed a novel substance that could serve as a prototype for the development of drugs to treat Alzheimers and other brain diseases.